Initial Results from Phase 2 COBRA Study in Colorectal Cancer

Opinion
Video

Stacey Cohen, MD, reviews the initial results from the phase 2 COBRA study focused on ctDNA as a predictive biomarker in adjuvant chemotherapy for patients with stage II colon cancer.

Recent Videos
4 experts are featured in this series.
4 experts are featured in this series.
Related Content